quantisnow
FeedTopReportsPricing
⌘K
Live feed
01:17:14·2048d
PRRelease
Aimmune Therapeutics, Inc. logo

Nestlé commences tender offer for Aimmune Therapeutics, Inc.

AIMT· Aimmune Therapeutics, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • AIMT
    Aimmune Therapeutics, Inc.
    Health Care

Related

  • 13D/G1892d
    SEC Form SC 13G/A filed
  • PR2016d
    Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
  • PR2018d
    Nestlé completes acquisition of Aimmune Therapeutics
  • PR2019d
    Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
  • PR2019d
    Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
  • PR2029d
    Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
  • PR2044d
    ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
  • PR2045d
    Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022